Testing a freezing tool on donated lungs for transplant
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new freezing tool (cryoprobe) used during lung transplant surgery to see if it can safely destroy abnormal tissue. The procedure is done on the lungs after they are removed from the body, so it does not affect the patient directly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a lung transplant surgery.
- You are not a healthy organ donor whose lungs could be used for transplant.
- You are not generally healthy without major lung disease.
- You do not have an active lung infection at the time of transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a robot that helps doctors freeze lung tumors using a CT scanner. It is for people with lung cancer who cannot have surgery and may benefit from a less invasive freezing treatment.
This trial compares two ways to freeze and destroy small lung tumors: through the chest wall or through the airways. It’s for people with early-stage lung cancer who are not able or willing to have surgery.
This trial compares a new method called cryo biopsy to standard forceps biopsy for diagnosing lung lesions. It may help get better tissue samples with fewer procedures.
This study looks at how blood vessels near lung tumors affect a freezing treatment called cryoablation, and tests a method to block vessels before treatment to make it safer and more effective.
This study tests a freezing treatment (cryoablation) for lung nodules that look like ground glass and are confirmed to be cancer. It's for people who cannot or choose not to have surgery or radiation.
This trial tests a new combination of a special scope (CLE) with a freezing biopsy tool to see if it can better diagnose lung spots found on CT scans. It may help you get a clearer diagnosis with fewer risks.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.